LABORATORY RESEARCH The Ascidian Natural Product Eusynstyelamide B Is a Novel Topoisomerase II Poison that Induces DNA Damage and Growth Arrest in Prostate and Breast Cancer Cells The authors investigated the mechanism of action of eusynstyelamide B (EB) in cancer cell lines of the prostate and breast. EB inhibited cell growth and induced a G2 cell cycle arrest, as shown by a significant increase in the G2/M cell population in the absence of elevated levels of the mitotic marker phospho-histone H3. [Oncotarget] Full Article Inhibition of Pten Deficient Castration Resistant Prostate Cancer by Targeting of the SET – PP2A Signaling Axis Researchers showed that targeting the endogenous PP2A regulator, SET, is a viable strategy to inhibit prostate cancers that are resistant to androgen deprivation therapy. [Sci Rep] Full Article Nucleoporin 62 and Ca2+/Calmodulin Dependent Kinase Kinase 2 Regulate Androgen Receptor Activity in Castrate Resistant Prostate Cancer Cells Ca2+/calmodulin-dependent kinase kinase 2 was previously shown to regulate androgen receptor activity in androgen-responsive prostate cancer cells. The authors explored the basis of this regulation in castrate-resistant prostate cancer cells. [Prostate] Abstract Inhibiting Inducible miR-223 Further Reduces Viable Cells in Human Cancer Cell Lines MCF-7 and PC3 Treated by Celastrol Investigators report that celastrol treatment can elevate miR-223 in human breast cancer cell line MCF-7 and prostate cancer PC3. Down-regulating miR-223 could increase the number of viable cells, yet it further reduced viable cells in samples that were treated by celastrol; up-regulation of miR-223 displayed opposite effects. [BMC Cancer] Full Article Curcumin Analog WZ35 Induced Cell Death via ROS-Dependent ER Stress and G2/M Cell Cycle Arrest in Human Prostate Cancer Cells Researchers showed that WZ35 exhibited much higher cell growth inhibition than curcumin by inducing ER stress-dependent cell apoptosis in human prostate cells. The reduction of CHOP expression by siRNA partially abrogated WZ35-induced cell apoptosis. [BMC Cancer] Full Article Network Analysis of an In Vitro Model of Androgen-Resistance in Prostate Cancer Researchers developed an in vitro model of androgen-resistance to characterize molecular changes occurring as androgen resistance evolves over time. They aimed to understand biological network profiles of transcriptomic changes occurring during the transition to androgen-resistance and to validate these changes between the in vitro model and clinical datasets. [BMC Cancer] Full Article Topoisomerase 2 Alpha Cooperates with Androgen Receptor to Contribute to Prostate Cancer Progression Scientists showed that DNA topoisomerase 2 alpha promotes tumor aggressiveness by inducing chromosomal rearrangements of genes that contribute to a more invasive phenotype. Anti-androgen treatment alone was ineffective in killing TOP2A overexpressing cells due to activation of an androgen receptor network. [PLoS One] Full Article Kindlin-2 Promotes Invasiveness of Prostate Cancer Cells via NF-κB-Dependent Upregulation of Matrix Metalloproteinases Researchers investigated the role of kindlin-2, an integrin-binding focal adhesion protein, in the regulation of invasiveness of prostate cancer. [Gene] Abstract CLINICAL RESEARCH Temsirolimus Maintenance Therapy after Docetaxel Induction in Castration-Resistant Prostate Cancer The authors designed a single-arm Phase II trial to explore whether the mTOR inhibitor temsirolimus can maintain the response to docetaxel without compromising quality of life. [Oncologist] Abstract |